Stock comparison
JOHNSON & JOHNSON is 69.5x more valuable than Alkermes plc. by market capitalization ($622.64 B vs $8.96 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 69.5x more valuable than Alkermes plc. by market capitalization ($622.64 B vs $8.96 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 69.5x more valuable than Alkermes plc. by market capitalization ($622.64 B vs $8.96 B).
Revenue leader
JNJ
ALKS: $1.48B vs JNJ: $94.19B.
Profit leader
JNJ
ALKS: $241.70M vs JNJ: $26.80B.
Margin leader
JNJ
ALKS: 16.4% vs JNJ: 28.5% net margin.
| Metric | ALKS | JNJ |
|---|---|---|
| Market cap | $8.96 B | $622.64 B |
| US-listed rank | #1026 | #18 |
| Revenue (latest FY) | $1.48B | $94.19B |
| Net income (latest FY) | $241.70M | $26.80B |
| Net margin | 16.4% | 28.5% |
| P/E (trailing FY) | 37.1x | 23.2x |
| SEC filings | 1,884 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 69.5x more valuable than Alkermes plc. by market capitalization ($622.64 B vs $8.96 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Alkermes plc. and JOHNSON & JOHNSON, or browse the full rankings.